| Product NDC: | 42023-123 |
| Proprietary Name: | Dantrium |
| Non Proprietary Name: | dantrolene sodium |
| Active Ingredient(s): | 20 mg/60mL & nbsp; dantrolene sodium |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 42023-123 |
| Labeler Name: | JHP Pharmaceuticals LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018264 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080801 |
| Package NDC: | 42023-123-06 |
| Package Description: | 6 VIAL in 1 CARTON (42023-123-06) > 60 mL in 1 VIAL |
| NDC Code | 42023-123-06 |
| Proprietary Name | Dantrium |
| Package Description | 6 VIAL in 1 CARTON (42023-123-06) > 60 mL in 1 VIAL |
| Product NDC | 42023-123 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | dantrolene sodium |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20080801 |
| Marketing Category Name | NDA |
| Labeler Name | JHP Pharmaceuticals LLC |
| Substance Name | DANTROLENE SODIUM |
| Strength Number | 20 |
| Strength Unit | mg/60mL |
| Pharmaceutical Classes | Decreased Striated Muscle Contraction [PE],Decreased Striated Muscle Tone [PE],Skeletal Muscle Relaxant [EPC] |